TRENDING TOPICS
538 articles found for "tax"
Stock futures climb to record levels as investors position for the Fed's January decision and a massive week of tech earnings from Microsoft, Meta, Tesla, and Apple.
AT&T reports better-than-expected Q4 2025 results with strong subscriber additions in both wireless and fiber, validating its converged connectivity strategy.
LVMH reported 2025 full-year results showing €80.8 billion revenue and €17.8 billion operating profit, navigating a disrupted global environment with organic growth returning in H2.
As Big Tech prepares to report earnings, Wall Street grapples with a fundamental question: Will $470 billion in 2026 AI capital expenditures generate returns that justify record valuations?
Humana shares plunge more than 20% after the Trump administration proposes just 0.09% Medicare Advantage rate increase for 2027, far below the 5-6% Wall Street expected.
Tesla will require new Full Self-Driving users to pay $99 monthly after February 14, eliminating the one-time $8,000 purchase option. The move comes ahead of Wednesday's Q4 earnings.
U.S. auto sales forecast to drop to 15.8 million units in 2026, down 2.4% from 2025. Average new vehicle prices at $50,000 have pushed middle-class buyers out of the market.
Vanguard recommends shifting from traditional 60/40 to 40/60 portfolio allocation, expecting only 4.5% annual equity returns over the next decade versus 15% historical average.
India and the European Union announce landmark free trade agreement eliminating tariffs on 96.6% of goods. The deal aims to boost bilateral trade from $136.5 billion to $200 billion by 2030.
W.R. Berkley reports record Q4 operating earnings of $450 million with combined ratio of 89.4%. The specialty insurer outlines significant AI investment plans for 2026-2027.
SEC Chair Paul Atkins signals imminent release of framework allowing crypto entrepreneurs to launch products without navigating burdensome legacy regulations.
UnitedHealth, Humana, and CVS plunge for a second day as the Trump administration's flat Medicare Advantage rates collide with a DOJ investigation into billing practices.